Physiologic mechanisms of action of lovastatin in nephrotic syndrome

Physiologic mechanisms of action of lovastatin in nephrotic syndrome

The effects of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors on the metabolism of apolipoprotein (apo) B-containing lipoproteins appear to differ according to the predominant lipoprotein profiles present and the condition being treated. In familial hypercholesterolemia, with i...

Full description

Bibliographic Details
Main Authors:	C A Aguilar-Salinas, P H Barrett, J Kelber, J Delmez, G Schonfeld
Format:	Article
Language:	English
Published:	Elsevier 1995-01-01
Series:	Journal of Lipid Research
Online Access:	http://www.sciencedirect.com/science/article/pii/S0022227520397662

Similar Items

Cholesteryl ester storage disease: complex molecular effects of chronic lovastatin therapy.
by: R Levy, et al.
Published: (1992-07-01)

Novel insights into the anti-tumour mechanism of action of apomine and its synergistic interaction with lovastatin in myeloma cells in vitro
by: Roelofs, A, et al.
Published: (2006)

Antiproteinuric action of amiloride in paediatric patient with corticoresistant nephrotic syndrome
by: Miguel Liern, et al.
Published: (2021-05-01)

Coagulopathy in the nephrotic syndrome
by: Sneha P Simon, et al.
Published: (2020-01-01)

Mechanisms of Glucocorticoid Resistance in Idiopathic Nephrotic Syndrome
by: Ruochen Che, et al.
Published: (2013-09-01)

Transdermal lovastatin enhances fracture repair in rats.
by: Gutierrez, G, et al.
Published: (2008)

Lovastatin upregulates chondrocyte marker expression in tenocytes
by: Cornell, H, et al.
Published: (2010)

NEPHROTIC CRISIS — AN URGENT CONDITION IN PATIENTS WITH NEPHROTIC SYNDROME
by: L V Kozlovskaya, et al.
Published: (2012-06-01)

Pathogenetic mechanisms of idiopathic minimal-change nephrotic syndrome
by: V. A. Obukhova
Published: (2016-03-01)

MECHANISMS OF RESISTANCE TO IMMUNOSUPPRESSIVE THERAPY IN PATIENTS WITH NEPHROTIC SYNDROME
by: S. L. Morozov, et al.
Published: (2017-09-01)

Epigenetic Mechanisms and Nephrotic Syndrome: A Systematic Review
by: Samantha Hayward, et al.
Published: (2023-02-01)

Toxocariasis and nephrotic syndrome
by: Yosra Ben Ariba, et al.
Published: (2019-01-01)

Atherothrombosis in the Nephrotic Syndrome
by: Joven Jorge
Published: (2000-01-01)

Nephrotic Syndrome in Children
by: Deepak Viswanath
Published: (2013-01-01)

Complications of nephrotic syndrome
by: Se Jin Park, et al.
Published: (2011-08-01)

Hypolipidemic effectiveness and safety of generic lovastatin
by: D. M. Aronov, et al.
Published: (2006-12-01)

Lovastatin-mediated changes in human tendon cells
by: Kuzma-Kuzniarska, M, et al.
Published: (2015)

Lovastatin-Mediated Changes in Human Tendon Cells
by: Kuzma-Kuzniarska, M, et al.
Published: (2015)

Structural basis for the biosynthesis of lovastatin
by: Jialiang Wang, et al.
Published: (2021-02-01)

Editorial: Nephrotic Syndrome in Pediatric Patients
by: Robert P. Woroniecki, et al.
Published: (2017-08-01)

An overview on the therapeutic potential and anticancer mechanism of Monacolin K / Lovastatin
by: Monu Monu, et al.
Published: (2022-12-01)

Lovastatin modulates chondrocyte cell cycle and matrix output
by: Cornell, H, et al.
Published: (2008)

Disseminated "Shingles" in the nephrotic syndrome
by: Kumar Sunil, et al.
Published: (2010-01-01)

Thromboembolic complications in nephrotic syndrome
by: Larisa A. Bobrova, et al.
Published: (2020-07-01)

Editorial: Nephrotic Syndrome in Children
by: Sami A. Sanjad, et al.
Published: (2021-11-01)

Treatment of Genetic Forms of Nephrotic Syndrome
by: Markus J. Kemper, et al.
Published: (2018-03-01)

A rare cause of nephrotic syndrome
by: Remi George Thomas, et al.
Published: (2020-01-01)

Predictive risk factors of steroid dependent nephrotic syndrome in children with idiopathic nephrotic syndrome
by: Ehsan Valavi, et al.
Published: (2023-06-01)

Recurrence of nephrotic syndrome following kidney transplantation in a child with congenital nephrotic syndrome
by: Ali Derakhshan, et al.
Published: (2016-01-01)

Method for producing lovastatin from biomass.
by: Liang , Juan Boo, et al.
Published: (2010)

Microbial transformation of lovastatin by Beauveria bassiana
by: Lirui Qiao, et al.
Published: (2012-06-01)

Effects of Lovastatin on Brain Cancer Cells
by: Efosa Amadasu, et al.
Published: (2022-06-01)

HYPERTENSION IN CHILDREN WITH NEPHROTIC SYNDROME
by: FARiS M. FRANKUL, et al.
Published: (2005-04-01)

Management of patients with nephrotic syndrome
by: Seigneux de
Published: (2009-07-01)

Nephrotic Syndrome in Children with This Condition
by: Masoud Rezagholizamenjany, et al.
Published: (2019-02-01)

Nephrotic Syndrome Associated with Thymoma
by: Sheng-Yen Hsiao, et al.
Published: (2014-12-01)

Nephrotic syndrome and Obstetric anesthesia
by: Vijay Kumar Nagpal, et al.
Published: (2017-01-01)

Improved methanol-derived lovastatin production through enhancement of the biosynthetic pathway and intracellular lovastatin efflux in methylotrophic yeast
by: Yiqi Liu, et al.
Published: (2018-05-01)

Mechanisms for cholesterol homeostasis in rat jejunal mucosa: effects of cholesterol, sitosterol, and lovastatin
by: Lien B. Nguyen, et al.
Published: (2001-02-01)

CHILD syndrome: successful treatment of skin lesions with topical lovastatin and cholesterol lotion
by: Karina Romero Sandoval, et al.
Published: (2019-07-01)